Skip to content

Author

Jing-Meng Li

We have 1 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Mechanisms of acquired resistance to osimertinib in EGFR T790M-Positive lung adenocarcinoma

Remarkable heterogeneity characterizes the resistance mechanisms emerging against osimertinib in EGFR T790M-positive lung adenocarcinoma, with EGFR secondary mutations, bypass signaling pathway activation, and histological transformation representing the primary categories.

Ke-Fan Cui, Ren-Jie Zhu, Jing-Meng Li · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.